Learn more

SUZHOU STAINWEI BIOTECH INC

Overview
  • Total Patents
    25
  • GoodIP Patent Rank
    160,016
  • Filing trend
    ⇩ 33.0%
About

SUZHOU STAINWEI BIOTECH INC has a total of 25 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2007. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ADICET BIO INC, SERAGEN INC and BOGOCH SAMUEL.

Patent filings in countries

World map showing SUZHOU STAINWEI BIOTECH INCs patent filings in countries

Patent filings per year

Chart showing SUZHOU STAINWEI BIOTECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhou Qunmin 23
#2 Hu Hongqun 23
#3 Xu Yiqing 19
#4 Luo Shiping 19
#5 Song Xiaoqi 19
#6 Chen Zui 18
#7 Cai Mingwen 15
#8 Zhou Jianying 9
#9 Chen Siyu 7
#10 Shi Donghong 7

Latest patents

Publication Filing date Title
CN109053892A The monoclonal antibody and the preparation method and application thereof of specific bond people and monkey CD38 antigen
CN108997497A The monoclonal antibody and the preparation method and application thereof of specific bond hostage's film film bubble related protein PV-1
WO2018195912A1 Ophthalmic pharmaceutical composition and use thereof
CN106939049A Antagonism suppresses the antigens of people PD 1 and the monoclonal antibody of its ligand binding and preparation method and application
CN104560884A Monoclonal antibodies for antagonizing and inhibiting combination of programmed death-1 (PD-1) and ligands of PD-1, hybridoma cell line secreting monoclonal antibodies and application of monoclonal antibodies
CN104558177A Monoclonal antibody capable of antagonizing and inhibiting bonding of programmed death-1 receptor (PD-1) and ligand thereof as well as encoding sequence and use of monoclonal antibody
CN103865878A Monoclonal antibody for antagonistic inhibition of combination of vascular endothelial cell growth factor and receptor thereof, hybridoma cell line secreting monoclonal antibody, and use of monoclonal antibody
CN103864932A Monoclonal antibody for antagonistically inhibiting combination of vascular endothelial growth factor with its receptor, and coding sequence and use thereof
CN102219854A Monoclonal antibody of anti-human PIGF (placental growth factor) protein as well as preparation method and application thereof
CN102124100A A monoclonal antibody specifically binding to VEGF and the hybridoma secreting same and uses thereof
CN101497883A Expression production and separation purification of recombinant placenta growth factor and chemical marker thereof
CN101486760A Recombinant protein capable of combining with vascular endothelial cell growth factor and placenta growth factor, as well as preparation method and application thereof
CN101418042A Separation and purification of recombinant human blood vessel endothelia cell growth factor, chemical labeling in vitro and use thereof